Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability, Tolerability, and Adherence of Three Rectal Microbicide Placebo Formulations Among HIV Seronegative Cisgender Men, Transgender Men and Transgender Women Who Engage in Receptive Anal Intercourse

NCT03671239 is registered in ClinicalTrials.gov with Microbicide Trials Network as lead sponsor.

NCT NCT03671239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03671239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability, Tolerability, and Adherence of Three Rectal Microbicide Placebo Formulations Among HIV Seronegative Cisgender Men, Transgender Men and Transgender Women Who Engage in Receptive Anal Intercourse
Lead sponsor
Microbicide Trials Network
Phase
Not applicable
Overall status
Completed
Start date
April 26, 2019
Completion date
July 27, 2020
Enrollment
217 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hiv prevention